Sign inGet started

Kim Dong

Insider CIK 1920163 · URGN Chief Financial Officer

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
URGN UroGen Pharma Ltd. M Exercise deriv2024-09-092024-09-122,500— $05,000SEC↗
URGN UroGen Pharma Ltd. M Exercise2024-09-092024-09-122,500— $037,753SEC↗
URGN UroGen Pharma Ltd. A Award deriv2024-01-312024-02-0212,000— $012,000SEC↗
URGN UroGen Pharma Ltd. M Exercise deriv2024-01-312024-02-023,333— $06,667SEC↗
URGN UroGen Pharma Ltd. M Exercise2024-01-312024-02-023,333— $026,585SEC↗
URGN UroGen Pharma Ltd. M Exercise2024-01-312024-02-123,333— $035,253SEC↗
URGN UroGen Pharma Ltd. A Award deriv2023-09-072023-09-087,500— $07,500SEC↗
URGN UroGen Pharma Ltd. A Award deriv2023-01-312023-02-0238,000— $038,000SEC↗
URGN UroGen Pharma Ltd. A Award deriv2023-01-312023-02-0210,000— $010,000SEC↗
URGN UroGen Pharma Ltd. A Award deriv2022-03-252024-02-1220,000— $020,000SEC↗
URGN UroGen Pharma Ltd. A Award deriv2022-03-252022-03-2930,000— $030,000SEC↗